Search research articles
Contact Us
Filters
Showing results (241-250 of 459) with videos related to
Page
of 46
Sort By:
Annals of Clinical and Translational Neurology
|
October 24, 2018
[<sup>18</sup>F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
Richard W Bevan-Jones, Thomas E Cope, Simon P Jones, et al.
Nature Communications
|
November 11, 2024
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases
Evgeniia Lobanova, Yu P Zhang, Derya Emin, et al.
Journal of Neurology
|
March 26, 2025
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism
David P Vaughan, Raquel Real, Marte Theilmann Jensen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 1, 2019
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features
Audrey Low, Elijah Mak, Maura Malpetti, et al.
Neuroimage
|
March 22, 2002
Initial demonstration of in vivo tracing of axonal projections in the macaque brain and comparison with the human brain using diffusion tensor imaging and fast marching tractography
Geoffrey J M Parker, Klaas E Stephan, Gareth J Barker, et al.
Brain Communications
|
September 6, 2021
[<sup>18</sup>F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases
Elijah Mak, Antonina Kouli, Negin Holland, et al.
Science Advances
|
October 29, 2021
In vivo rate-determining steps of tau seed accumulation in Alzheimer's disease
Georg Meisl, Eric Hidari, Kieren Allinson, et al.
BMJ Open
|
December 15, 2022
New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol
Juliette Helene Lanskey, Ece Kocagoncu, Andrew J Quinn, et al.
BMC Neurology
|
November 22, 2014
The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing
Meredith A Shafto, Lorraine K Tyler, Marie Dixon, et al.
Brain : a Journal of Neurology
|
May 22, 2020
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
Alexander G Murley, Ian Coyle-Gilchrist, Matthew A Rouse, et al.
Page
of 46
Search research articles
Search
Showing results (241-250 of 459) with videos related to
Sort By:
Page
of 46
Annals of Clinical and Translational Neurology
|
October 24, 2018
[<sup>18</sup>F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
Richard W Bevan-Jones, Thomas E Cope, Simon P Jones, et al.
Nature Communications
|
November 11, 2024
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases
Evgeniia Lobanova, Yu P Zhang, Derya Emin, et al.
Journal of Neurology
|
March 26, 2025
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism
David P Vaughan, Raquel Real, Marte Theilmann Jensen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 1, 2019
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features
Audrey Low, Elijah Mak, Maura Malpetti, et al.
Neuroimage
|
March 22, 2002
Initial demonstration of in vivo tracing of axonal projections in the macaque brain and comparison with the human brain using diffusion tensor imaging and fast marching tractography
Geoffrey J M Parker, Klaas E Stephan, Gareth J Barker, et al.
Brain Communications
|
September 6, 2021
[<sup>18</sup>F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases
Elijah Mak, Antonina Kouli, Negin Holland, et al.
Science Advances
|
October 29, 2021
In vivo rate-determining steps of tau seed accumulation in Alzheimer's disease
Georg Meisl, Eric Hidari, Kieren Allinson, et al.
BMJ Open
|
December 15, 2022
New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol
Juliette Helene Lanskey, Ece Kocagoncu, Andrew J Quinn, et al.
BMC Neurology
|
November 22, 2014
The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing
Meredith A Shafto, Lorraine K Tyler, Marie Dixon, et al.
Brain : a Journal of Neurology
|
May 22, 2020
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
Alexander G Murley, Ian Coyle-Gilchrist, Matthew A Rouse, et al.
Page
of 46